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Pleurocidin (Ple) is a 25-residue peptide which is derived from the skin mucous secretion of the winter flounder (Pleuronectes americanus). In
this study, we investigated antifungal effects and its mode of action of Ple on human pathogenic fungi. Ple showed potent antifungal activity with
low hemolytic activity. To investigate the antifungal mechanisms of Ple, the cellular localization and membrane interaction of Ple were examined.
Protoplast regeneration and membrane-disrupting activity by DPH-labeled membrane support the idea, that Ple exerts fungicidal activity against
the human pathogenic fungus Candida albicans with the disruption of a plasma membrane. To aim for which was the application of a therapeutic
agent, we designed a synthetic enantiomeric peptide composed of all-D-amino acids to enhance proteolytic resistance. The synthetic all-D-Ple also
displayed two-fold more potent antifungal activity than that of all-L-Ple, and its antifungal activity showed proteolytic resistance against various
proteases. Therefore, these results suggest a therapeutic potential of all-D-Ple with regard to its proteolytic resistance against human fungal
infections.
© 2007 Elsevier B.V. All rights reserved.Keywords: Pleurocidin; Antimicrobial peptide; Fungicidal activity; Membrane disrupting activity; Protease resistance1. Introduction
For the last few decades, a wide array of peptides exhibiting
broad-spectrum antimicrobial activity has been discovered in
plants, insects, and higher animals [1–4]. Among the peptides,
polycationic antimicrobial peptides play an important role in
innate immunity [5,6], and they inactivate microbes through a
general mechanism by binding preferentially to microbial
membranes which causes membrane disruption [7,8]. Numer-
ous cationic peptides have been identified in nature and have
been created by design [9–13] and vary fairly in various lengths
which exhibit a range of 11–50 amino acids, amino acid
sequence, and secondary structure including α-helices, β-
sheets, loops, and proline-/arginine-rich peptides [14]. A great⁎ Corresponding author. Tel.: +82 53 950 5373; fax: +82 53 955 5522.
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doi:10.1016/j.bbamem.2007.02.024number of peptides occur in most the organisms, but these
peptides have two common features; they exhibit a net positive
charge of more than +2 by positively-charged amino acids, and
amphipathic three-dimensional structures are comprised of
hydrophilic and hydrophobic faces [15]. These features seem to
play an essential role in their mode of action, which has been
reported by many studies regarding the membrane permeabi-
lization of cationic antimicrobial peptides and cell death.
Ple (GWGSFFKKAAHVGKHVGKAALTHYL-NH2), a
25-residue peptide, is an α-helical cationic peptide derived from
the skin-secreted mucous of the winter flounder (Pleuronectes
americanus) [16]. This peptide has been reported to exhibit
broad antibacterial activity against Gram-negative and Gram-
positive bacteria. Ple displays primary sequence homology,
with dermaseptins, from the skin of the arboreal frog Phyllo-
medusa bicolor [17] and ceratatoxins [18], and possesses an
amphipathic α-helical structure [19]. Due to the importance of
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regarding its correlation between antibacterial activity and
membrane-disrupting activity [20]. Though there are some
results which show antifungal effects on Candida albicans
[21,22], there have not been any reports, however, concerning
the antifungal mechanism of Ple which lead to the cell death of
fungi.
On the other hand, most natural antimicrobial peptides are
very sensitive to enzymatic degradation by proteases in serum,
and furthermore, faults create difficulty for developing peptidic
therapeutic agents. To overcome this problem, wholly or
partially L-amino acids of antimicrobial peptide were replaced
with D-amino acids. It has been reported that these substitution
can improve antimicrobial activity and proteolytic stability [23].
Thus, the substitution of D-amino acid could be a strategy for
proteases-resistant antimicrobial peptides in clinical therapeutic
use.
In this study, we investigated the antifungal activity of Ple,
and elucidated the mode of action by tracing peptides and
examining membrane disruption in fungal cells. In addition, we
synthesized all-D-Ple, and investigated its protease-resistance by
enzymatic degradation and antifungal activity in the presence of
proteases.2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized by the solid-phase method using Fmoc(9-
fluorenyl-methoxycarbonyl)-chemistry [24]. Rink amide 4-methyl benzhydry-
lamine (MBHA) resin (0.55 mmol/g) was used as the support to obtain a C-
terminal amidate peptide. The coupling of Fmoc-amino acids was performed
with N-hydroxybenzotriazole (HOBt) and dicyclohexylcarbodiimide (DCC).
Amino-acid side chains were protected as follows: tert-butyl (Asp), trityl (Gln),
and tert-butyloxycarbonyl (Lys). Deprotection and cleavage from the resin were
carried out using a mixture of trifluoroacetic acid, phenol, water, thioanisole,
1,2-ethanedithiol, and triisopropylsilane (88 : 2.5 : 2.5 : 2.5 : 2.5 : 2.0, v/v) for
2 h at room temperature. The crude peptide was repeatedly washed with a
diethylether, dried in a vacuum, and purified using a reversed-phase preparative
HPLC on a Waters 15-μm Deltapak C18 column (19×30 cm). The purity of the
peptide was checked by analytical reversed-phase HPLC on an Ultrasphere C18
column (Beckman, USA), 4.6×25 cm. The purified peptides were hydrolyzed
with 6 N-HCl for 22 h at 110 °C, and then dried in a vacuum. The residues were
dissolved in 0.02 N HCl and subjected to an amino acid analyzer (Hitachi
Model, 8500 A, Japan). Peptide concentration was determined by amino acid
analysis. The molecular weights of the synthetic peptides were determined using
a matrix-assisted laser desorption ionization MALDI-mass spectrometer [25].
2.2. Fungal strains and antifungal activity assay
Saccharomyces cerevisiae (KCTC 7296), Trichosporon beigelii (KCTC
7707) and Malassezia furfur (KCTC 7744) were obtained from the Korean
Collection for Type Cultures (KCTC) of the Korea Research Institute of
Bioscience and Biotechnology (KRIBB), Daejon, Korea. C. albicans (TIMM
1768) was obtained from the Center for Academic Societies, Osaka, Japan.
The fungal strains were grown at 28 °C in YPD (2.0% dextrose, 2.0%
peptone, 1.0% yeast extract) medium. The fungal cells were seeded on the well
of a 96-microtiter plate in YPD medium at a density of 2×103 cells (100 μl per
well). A serially-diluted peptide solution was added to each well, and the cell
suspension was incubated for 24 h at 28 °C. After incubation, 5 μl of a 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) solution
[5 mg/ml MTT in a phosphate-buffered saline (PBS), pH 7.4] were added toeach well, and the plates were incubated for 4 h at 37 °C. Thirty microliters of a
20% (w/v) SDS solution, containing 0.02M HCl, were then added and the plates
were incubated for 16 h at 37 °C to dissolve the formazan crystals that had
formed [26,27]. The absorbance of each well was measured at 580 nm by a
microtitrator ELISA Reader (Molecular Devices Emax, California, USA).
2.3. Hemolytic activity assay
The hemolytic activity of the peptides was evaluated by determining the
amount of released hemoglobin of a 8% suspension of fresh human red blood
cells (RBCs) at 414 nm [28]. Human RBCs were harvested and washed with a
PBS (35 mM phosphate buffer/0.15 M NaCl, pH 7.0) three times. One hundred
microliters of human RBCs, diluted to 16% (v/v) in PBS, was seeded on 96-well
plates, and then 100 μl of the peptide solution (from 100 to 0.39 μM) was added
to each well. The plates were incubated for 1 h at 37 °C. One hundred-microliter
aliquots were transferred to new 96-well plates, and hemolysis was measured by
absorbance at 414 nm via an ELISA plate Reader (Molecular Devices Emax,
California, USA). Zero and 100% hemolysis was determined in a PBS and 0.1%
Triton X-100, respectively. The hemolysis percentage was calculated by
employing the following equation:
Percentage hemolysis=[(Abs414 nm in the peptide solution−Abs414 nm in a
PBS) / (Abs414 nm in 0.1% Triton X-100−Abs414 nm in PBS)]×100.
2.4. Cell wall regeneration of protoplast
The C. albicans protoplasts were prepared by treatment with a 10 mM
phosphate buffer (pH 6.0), containing 0.8 M NaCl, Novozyme 234 (Sigma,
Louis, USA) (5 mg/ml) and Cellulase (Sigma, Louis, USA) (5 mg/ml) for 3 h at
30 °C with gentle agitation. The obtained protoplasts were centrifuged at 700×g
for 10 min and then suspended in a 50 mM Tris–HCl buffer (pH 7.5), containing
0.8 M NaCl, and 10 mM CaCl2. The protoplasts were detected by phase contrast
light microscopy (NIKON, ECLIPSE TE200, Japan). Peptide solutions, with a
final concentration of 20 μM, were added to the protoplasts, and incubated for
3 h at 28 °C. The peptide-treated protoplasts were transferred to YPD soft-agar
solutions containing 0.8 M NaCl and 2% agar. The plates were incubated for
5 days at 28 °C to allow for the regeneration of colonies.
2.5. Measurement of plasma membrane fluorescence anisotropy
Fluorescence from the plasma membrane of C. albicans cells labeled by 1,6-
diphenyl-1,3,5-hexatriene (DPH) (Sigma, Japan) were used to monitor changes
in membrane dynamics. Labeling and fluorescence measurement were
performed, exactly as described [29]. Fungal cells were treated with peptides
in the concentration range between 0 and 5 μM within MIC values and
incubated for 2 h at 28 °C. Samples of the fungal culture were fixed by 0.37%
formaldehyde, collected and washed with a PBS, and the cells were frozen by
liquid nitrogen. For labeling, cells were thawed with a PBS buffer and
resuspended in PBS. The suspension was incubated with 0.6 mM DPH for
45 min at 28 °C, and this was followed by washing with PBS buffer. Steady-state
fluorescence anisotropy was measured by a Spectrofluorometer (Shimadzu RF-
5301PC, Shimadzu, Japan) at 350 nm excitation and 425 nm emission
wavelengths [30].
2.6. The protease resistance of enantiomeric Ple
Two enantiomeric peptides (1 μg each) were dissolved in a 10 mM sodium
phosphate buffer (pH 7.6). A solution containing either a mixture of trypsin (EC
3.4.21.4., Sigma; 5 μg), plasmin (EC 3.4.21.7., Sigma; 5 μg), or carboxypepti-
dase B (EC 3.4.17.2., Sigma; 5 μg) was added to each enantiomer. After
incubation for 2 h at 37 °C, the peptides were subjected to 16.5% tricine-SDS-
PAGE. To determine the MICs of two peptides under protease, an antifungal
activity assay was performed by a micro-dilution method after enzymatic
degradation. The serially-diluted peptide solution was incubated with trypsin
(30 μg) for 2 h at 37 °C, and the protease inhibitor aprotinin (Sigma, Louis,
USA; 4 μg) was treated and incubated for 90 min at 37 °C. The culture of fungal
cells was suspended in a reaction mixture and MIC values were determined by a
previously described method.
Table 2
Fig. 1. The hemolytic activity of the peptides was evaluated by determining the
release of hemoglobin in 8% suspensions of fresh human red blood cells at
414 nm. The hemolysis percentage was calculated by employing the following
equation: % hemolysis=[(Abs414 nm in the peptide solution−Abs414 nm in PBS)/
(Abs414 nm in 0.1% Triton X-100−Abs414 nm in PBS)]×100. Cells incubated with
Ple (○), cells incubated with melittin (●).
1402 H.J. Jung et al. / Biochimica et Biophysica Acta 1768 (2007) 1400–14053. Results and discussion
3.1. Peptide synthesis and antifungal activity
Peptides were chemically synthesized by the solid phase
method, and they were identified by amino acid analysis and
MALDI mass spectroscopic analysis. Ple (GWGSFFKKAAH-
VGKHVGKAALTHYL-NH2) is a 25-residue peptide which
was isolated from the skin-secreted mucous of the winter
flounder (P. americanus). It has been reported to show broad
antibacterial activity against bacterial strains [19,20], while its
antifungal effects and mechanisms remain poorly understood.
Melittin, as a comparison in this study, is a 26-residue peptide
which is derived from the venom of the European honey bee
Apismellifera. Melittin is the most widely amphipathic, and
membrane-lytic α-helical peptide [31]. It also has been known
to possess broad antimicrobial activity due to the formation of
membrane pores [32] and it has strong hemolytic activity
toward mammalian cells [33].
The in vitro antifungal activity of Ple, against pathogenic
yeast strains, was determined by a MTT assay [27]. These
strains, such as C. albicans, T. beigelii, and M. furfur, exist as a
commensal of humans and are superficial contaminants that can
cause a variety of serious infections in humans. S. cerevisiae is a
universal yeast strain which has been studied regarding the
effects of drugs against yeast strains. All fungal strains tested are
highly susceptible to Ple with MIC values between 2.5 and 5 μM
(Table 1), however, the antifungal activity of Ple was less potent
than that of melittin with MIC values between 0.63 and 1.25 μM.
Although most antimicrobial peptides exhibited relatively
good cell selectivity, between microbial cells versus mammalian
host cells, some antimicrobial peptides show lytic activity
toward mammalian cells. It has been reported that membrane-
active antimicrobial peptides have displayed potent hemolytic
activity on mammalian erythrocytes [34]. Hemolysis by Ple was
measured against human red blood cells at various peptide
concentration levels (Fig. 1), by a microdilution method. Ple
showed very weak hemolytic activity even at its highest
concentration, while melittin exhibited strong hemolytic
activity regarding most tested concentration amounts. These
results demonstrated that Ple has remarkable antifungal activity
with very low hemolytic activity, and it suggests that Ple also
possesses fungal selectivity.
3.2. Membrane perturbing by interaction with fungal plasma
membrane
Antimicrobial peptides target cytoplasmic membrane and
intracellular macromolecules [35–40]. As a general feature,Table 1
The fungicidal activity of Ple
Peptides MIC (μM)
S. cerevisiae T. beigelii C. albicans
Ple 5 2.5 5
Melittin 1.25 0.63 1.25most antimicrobial peptides are an amphipathic, and this
property is a key role in antimicrobial activity by microbial
membrane interaction, however, microbial cell surfaces such as
membranes or cell wall, are composed of various components,
and they exhibited significant differences in surface compo-
nents between bacteria and fungi. In order to understand the
correlation between antifungal activity and cell-surface accu-
mulation, we examined the effects of the peptides on the cell
wall regeneration of C. albicans protoplasts. The cell wall
regeneration was used as an indication to access the degree of
membrane damage by antifungal activity [26]. As represented in
Table 2, the cell wall regeneration of the protoplasts, treated
with Ple, was much lower than the control which was not treated
with a peptide. These results indicate that the antifungal effects
of Ple are due to the accumulation of Ple within the plasma
membrane through interaction between peptides and the plasma
membrane, rather than with the cell wall. The results are also
supported by amphipathic α-helical conformation as the
structural feature of Ple, which is presented by Schiffer–
Edmundson helical wheel modeling and CD spectra; amphi-
pathic α-helical peptides, with antibacterial activity, exhibit
membrane-disrupting activity [41] and Ple also displays α-
helical structure in an aqueous solution, as well as in membraneThe effects of the peptides on the regeneration of C. albicans protoplast
Peptides F.R. a
Control b 90.6
Ple 9.2×10−1
Melittin 6.12×10−1
a Frequency of regeneration (F.R.) values were calculated by the formula: F.R.
(%)=[(number of colonies on plate) / (number of protoplasts used)]×100.
b Control indicates no peptide treatment.
Fig. 2. Measuring of the level of fluorescence in a fungal plasma membrane by
DPH labeling. Steady-state fluorescence anisotropy was measured by a RF-
5301PC spectrofluorometer. The excitation wavelength was set to 350 nm.
Fluorescence was detected through a cutoff emission filter and the emission
monochromator was set to 425 nm. (○) cells treated with Ple; (●) cells treated
with melittin.
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the membrane interaction of Ple, is a major cause of cell death
by most α-helical antimicrobial peptides, including melittin.
3.3. Changes in the plasma membrane dynamics of C. albicans
cells
To elucidate in vivo membrane fluidity by Ple in the
plasma membrane of C. albicans cells, changes in membraneFig. 3. Proteolytic resistance and the antifungal activity of all-L- and all-D-Ple. (A) Th
tricine-SDS-PAGE. (B) The MIC values of all-L- and all-D-Ple in the absence or predynamics were further examined with a fluorescent membrane
probe. DPH (1,6-diphenyl-1,3,5-hexatriene) is a hydrophobic
molecule and this property makes it possible to associate with
the hydrocarbon tail region of phospholipids, within the
cytoplasmic membrane, without disturbing the structure of the
lipid bilayer [43,44]. This fluorescent probe is commonly
applied to probe membrane structure and membrane biophy-
sics [45]. Membrane fluidity, by the activity of Ple, can be
measured by spectrofluorometric analysis using DPH mole-
cule. If the antifungal activity of Ple causes membrane
damage induced by membrane depolarization, DPH molecules
could not be incorporated with the lipophilic tails of
phospholipids in the lipid bilayer. As shown in Fig. 2,
increasing peptide concentration levels significantly decreased
plasma membrane DPH fluorescence anisotropy and DPH
anisotropic activity reflects the antifungal activity of Ple
against C. albicans cells, by perturbing the plasma membrane.
This suggests that the plasma membrane was structurally
perturbed when exposed to Ple, in exponentially-grown
cultures.
3.4. The effects of proteases on the antifungal activity of two
enantiomeric Ple
In considering many studies on antimicrobial peptides,
peptides have significant therapeutic potential. If peptides have
proteolytic resistance with the same level of antimicrobial
potency, it would be beneficial to have more effective
antimicrobial peptides with a long-active duration. To examine
the proteolytic resistance of all-L- and all-D-Ple, we investigated
the susceptibility of peptides to trypsin, plasmin and carbox-
ypeptidase B, with tricine-SDS-PAGE (Fig. 3A). As shown ine peptides were incubated with proteases for 2 h at 37 °C and subjected to 16.5%
sence of trypsin with C. albicans (a) and M. furfur (b).
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or absence of enzymes, while the all-L-Ple was extensively
degraded in the presence of enzymes. These results indicate the
stability of all-D-Ple toward proteolysis.
In order to investigate the effects of proteolytic resistance on
antifungal activity, we performed in vitro antifungal activity
assay in the presence of protease and described the MIC values
(Fig. 3B). The MIC values of all-D-Ple were similar for both
conditions with two pathogenic fungi; C. albicans is an
opportunistic pathogenic fungi that can lead to candidiasis
and it carries significant morbidity and mortality [46], and M.
furfur which is a yeast of the genus Malassezia that can form
part of the normal human cutaneous commensal flora, which
can cause cutaneous diseases and systemic diseases in animals
[47]. The MIC values of C. albicans and M. furfur were
determined at 5 μM and 0.31 μM, respectively. The MIC values
of all-D-Ple, however, were different. The MIC values of all-D-
Ple in the absence of trypsin were determined at 10 μM of C.
albicans and 0.63 μM of M. furfur, while those in the presence
of trypsin could not be calculated. These results indicated that
all-L-Ple did not demonstrate antifungal activity because of the
degradation by protease. It is interesting to note that all-D-Ple
demonstrated potent antifungal activity which was twice that of
all-L-Ple, in the absence of protease trypsin. Considering the
study by Chen et al. [48], we can infer that the long-active
duration by proteolytic resistance increases the potency of all-D-
Ple.
In addition, our study along with previous studies, has
demonstrated that the stability of peptides increases the
antimicrobial activity of peptides in vitro or in vivo. Actually,
Ple-amide displays an antibacterial activity and it significantly
reduced the mortality of coho salmon in vivo test, when it was
constantly delivered to Vibrio anguillarum-infected fish [49].
Therefore, all-D-Ple may have remarkable therapeutic potential
and could be a model for the design of a stable antimicrobial
peptide.
4. Conclusion
In this study, we investigated the antifungal activity and
mechanism of Ple, and synthesized enantiomeric analogues in
order to increase the resistance on proteolysis by proteases in
serum. Ple, a 25-mer peptide derived from P. americanus,
exhibited potent antifungal activity against human pathogenic
fungi without hemolytic activity. The membrane-disrupting
assay indicated that Ple can induce membrane damage thus
inhibiting the cellular functions of human pathogenic fungi. The
antifungal effects of Ple are thought to be due to membrane
disruption after the accumulation in the plasma membrane of
fungal cell.
On the other hand, substituting L-amino acid for D-amino
acid, in the whole sequence, remarkably increased proteolytic
resistance against serum proteases, and slightly increased its
activity. Therefore, Ple has potential as a therapeutic agent in
treating fungal infectious diseases without damaging human
erythrocytes, and all-D-Ple may be a model for design analogues
with proteolytic resistance toward serum proteases.Acknowledgement
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